| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $400.9M | +2.6% |
| Cost of Revenue | $104.0M | +5.8% |
| Gross Profit | $296.9M | +1.6% |
| R&D Expense | $70.9M | +3.7% |
| SG&A Expense | $79.3M | -4.9% |
| Operating Income | -$64.8M | +27.9% |
| Pre-tax Income | -$63.9M | +30.6% |
| Income Tax | $2.1M | +62.9% |
| Net Income | -$65.9M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.2M | -27.2% |
| Accounts Receivable | $109.7M | +8.0% |
| Current Assets | $346.6M | -15.5% |
| Total Assets | $523.8M | -15.6% |
| Current Liabilities | $290.9M | +0.1% |
| Total Liabilities | $395.7M | -3.1% |
| Stockholders' Equity | $128.0M | -39.6% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.9M | -18.3% |
| Capital Expenditures | $6.2M | -53.8% |
| Investing Cash Flow | -$6.2M | +53.8% |
| Financing Cash Flow | -$79.0M | -421.0% |
| Free Cash Flow | $11.7M | +38.3% |
| +29.3% |
| EPS (Basic) | -$0.53 | +27.4% |
| EPS (Diluted) | -$0.53 | +27.4% |